Related Experiment Video
Updated: Jun 11, 2025
09:21
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.4K
Approaches to Early Parkinson's Disease Subtyping
Michele Hu1, Casper Skjærbæk2, Per Borghammer2
1Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Journal of Parkinson'S Disease
|September 27, 2024
Summary
Early Parkinson's disease (PD) involves hidden pathology. Identifying distinct PD subtypes early using multi-dimensional markers is crucial for personalized medicine and effective drug development.
Area of Science:
- Neuroscience
- Neurology
- Genetics
Background:
- Parkinson's disease (PD) pathology and neurodegeneration precede motor symptoms, offering a window for early detection.
- Prodromal PD presents heterogeneity, suggesting distinct subtypes with varied clinical and pathophysiological profiles.
- Current understanding necessitates refined methods for identifying these early PD subtypes.
Purpose of the Study:
- To explore subtyping methodologies for prodromal and clinical Parkinson's disease.
- To highlight the need for integrated approaches combining clinical, imaging, genetic, and molecular markers.
- To emphasize the importance of theoretical disease models for understanding biological subtypes.
Main Methods:
- Review of clinical, imaging, genetic, and molecular subtyping approaches in PD.
- Integration of multi-omics data and subtle motor/non-motor symptom observation.
- Focus on data-driven approaches and multi-omics fingerprints for subtype definition.
Main Results:
- Evidence supports distinct subtypes within prodromal and diagnosed PD.
- Multi-dimensional classification can enhance understanding of PD pathophysiology.
- Subtyping promises improved predictions for clinical outcomes and treatment response.
Conclusions:
- Refining the definition and identification of prodromal PD subtypes is essential.
- A comprehensive, multi-dimensional strategy is required for accurate subtyping.
- Understanding biological subtypes through integrated markers will advance personalized medicine and drug discovery for Parkinson's disease.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
01:24Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K